Amgen Stock Hits New High After Beating Earnings Estimates

Shares of biotechnology company Amgen Inc. (NASDAQ:AMGN) hit a new 52-week high during mid-day trading on Wednesday, following a better-than-expected earnings announcement.

The stock traded as high as $414.97 and last traded at $411.57, with a volume of 1,073,411 shares traded.

Amgen reported quarterly earnings per share of $6.29, beating the consensus estimate of $5.62 by $0.67. The company's revenue was up 9.5% year-over-year to $10.05 billion, surpassing analysts' expectations of $9.43 billion.

Amgen also raised its FY 2026 guidance to $22.30-$23.50 earnings per share and $38.2-$39.4 billion in revenue, both above analyst estimates.